Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases

  • Lee, Chang Ho (Department of Pharmacology, College of Medicine, Hanyang University) ;
  • Kim, Jong-Hoon (Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University)
  • Received : 2014.01.06
  • Accepted : 2014.03.18
  • Published : 2014.07.15
⟨ Previous Next ⟩

Abstract

Ginseng is widely used for its promising healing and restorative properties as well as for its possible tonic effect in traditional medicine. Nowadays, many studies focus on purified individual ginsenoside, an important constituent in ginseng, and study its specific mechanism of action instead of whole-plant extracts on cardiovascular diseases (CVDs). Of the various ginsenosides, purified ginsenosides such as Rb1, Rg1, Rg3, Rh1, Re, and Rd are the most frequently studied. Although there are many reports on the molecular mechanisms and medical applications of ginsenosides in the treatment of CVDs, many concerns exist in their application. This review discusses current works on the countless pharmacological functions and the potential benefits of ginseng in the area of CVDs. Results: Both in vitro and in vivo results indicate that ginseng has potentially positive effects on heart disease through its various properties including antioxidation, reduced platelet adhesion, vasomotor regulation, improving lipid profiles, and influencing various ion channels. To date, approximately 40 ginsenosides have been identified, and each has a different mechanism of action owing to the differences in chemical structure. This review aims to present comprehensive information on the traditional uses, phytochemistry, and pharmacology of ginseng, especially in the control of hypertension and cardiovascular function. In addition, the review also provides an insight into the opportunities for future research and development on the biological activities of ginseng.

Keywords

References

  1. Gielen S, Landmesser U. The Year in Cardiology 2013: cardiovascular disease prevention. Eur Heart J 2014;35:307-12. https://doi.org/10.1093/eurheartj/eht551
  2. Lim KH, Ko D, Kim JH. Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats. J Ginseng Res 2013;37: 273-82. https://doi.org/10.5142/jgr.2013.37.273
  3. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700. https://doi.org/10.1016/S0140-6736(99)11181-4
  4. Toth PP. Making a case for quantitative assessment of cardiovascular risk. J Clin Lipidol 2007;1:234-41. https://doi.org/10.1016/j.jacl.2007.07.002
  5. Libby P. Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005;45:1600-2. https://doi.org/10.1016/j.jacc.2005.02.058
  6. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and Eselectin in human atherosclerosis. J Pathol 1993;171:223-9. https://doi.org/10.1002/path.1711710311
  7. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832-44. https://doi.org/10.1161/CIRCULATIONAHA.106.676890
  8. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997;54:1-8. https://doi.org/10.1016/S0006-2952(97)00193-7
  9. Buettner C, Yeh GY, Phillips RS, Mittleman MA, Kaptchuk TJ. Systematic review of the effects of ginseng on cardiovascular risk factors. Ann Pharmacother 2006;40:83-95.
  10. Lim KH, Lim DJ, Kim JH. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res 2013;37:283-92. https://doi.org/10.5142/jgr.2013.37.283
  11. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  12. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004;10:187-92.
  13. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26: 143-9. https://doi.org/10.1111/j.1745-7254.2005.00034.x
  14. Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007;13:381-404.
  15. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969;9:419-30. https://doi.org/10.1146/annurev.pa.09.040169.002223
  16. Bittles AH, Fulder SJ, Grant EC, Nicholls MR. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979;25:125-31. https://doi.org/10.1159/000212330
  17. Zhou DH. Preventive geriatrics: an overview from traditional Chinese medicine. Am J Chin Med 1982;10:32-9. https://doi.org/10.1142/S0192415X82000063
  18. Bolli R. Superoxide dismutase 10 years later: a drug in search of a use. J Am Coll Cardiol 1991;18:231-3. https://doi.org/10.1016/S0735-1097(10)80244-X
  19. Miller SC, Delorme D, Shan JJ. CVT-E002 stimulates the immune system and extends the life span of mice bearing a tumor of viral origin. J Soc Integr Oncol 2009;7:127-36.
  20. Samukawa K, Suzuki Y, Ohkubo N, Aoto M, Sakanaka M, Mitsuda N. Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties. Biorheology 2008;45:689-700.
  21. Li XT, Chen R, Jin LM, Chen HY. Regulation on energy metabolism and protection on mitochondria of Panax ginseng polysaccharide. Am J Chin Med 2009;37:1139-52. https://doi.org/10.1142/S0192415X09007454
  22. Li J, Ichikawa T, Jin Y, Hofseth LJ, Nagarkatti P, Nagarkatti M, Windust A, Cui T. An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 2010;130:222-30. https://doi.org/10.1016/j.jep.2010.03.040
  23. Sohn SH, Kim SK, Kim YO, Kim HD, Shin YS, Yang SO, Kim SY, Lee SW. A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells. J Ginseng Res 2013;37:442-50. https://doi.org/10.5142/jgr.2013.37.442
  24. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23:728-32. https://doi.org/10.1111/j.1440-1681.1996.tb01767.x
  25. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2005;41:861-8. https://doi.org/10.1016/j.jvs.2005.01.054
  26. Wang X, Chai H, Yao Q, Chen C. Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr 2007;44:493-9. https://doi.org/10.1097/QAI.0b013e3180322542
  27. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006;532:201-7. https://doi.org/10.1016/j.ejphar.2006.01.001
  28. Deng HL, Zhang JT. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin Med J (Engl) 1991;104:395-8.
  29. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302. https://doi.org/10.2174/157016109788340767
  30. He F, Guo R, Wu SL, Sun M, Li M. Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol 2007;50:314-20. https://doi.org/10.1097/FJC.0b013e3180cab12e
  31. Kim YM, Namkoong S, Yun YG, Hong HD, Lee YC, Ha KS, Lee H, Kwon HJ, Kwon YG, Kim YM. Water extract of Korean red ginseng stimulates angiogenesis by activating the Pi3k/Akt-dependent Erk1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol Pharm Bull 2007;30:1674-9. https://doi.org/10.1248/bpb.30.1674
  32. Leung KW, Yung KK, Mak NK, Yue PY, Luo HB, Cheng YK, Fan TP, Yeung HW, Ng TB, Wong RN. Angiomodulatory and neurological effects of ginsenosides. Curr Med Chem 2007;14:1371-80. https://doi.org/10.2174/092986707780597916
  33. Nakaya Y, Mawatari K, Takahashi A, Harada N, Hata A, Yasui S. The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through Pi3k/Akt and nitric oxide pathways. J Med Invest 2007;54:381-4. https://doi.org/10.2152/jmi.54.381
  34. Leung KW, Leung FP, Huang Y, Mak NK, Wong RN. Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett 2007;581:2423-8. https://doi.org/10.1016/j.febslet.2007.04.055
  35. Papapetropoulos A. A ginseng-derived oestrogen receptor beta (Erbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. Br J Pharmacol 2007;152:172-4. https://doi.org/10.1038/sj.bjp.0707360
  36. Lei Y, Gao Q, Chen KJ. Effects of extracts from Panax notoginseng and Panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro. Chin J Integr Med 2008;14:37-41. https://doi.org/10.1007/s11655-008-0037-0
  37. Hong SJ, Wan JB, Zhang Y, Hu G, Lin HC, Seto SW, Kwan YW, Lin ZX, Wang YT, Lee SM. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo. Phytother Res 2009;23:677-86. https://doi.org/10.1002/ptr.2705
  38. Wan JB, Lee SM, Wang JD, Wang N, He CW, Wang YT, Kang JX. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J Agric Food Chem 2009;57:6692-7. https://doi.org/10.1021/jf900529w
  39. Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent Pi3-kinase and Amp-activated protein kinase. Toxicol Appl Pharmacol 2010;246:171-83. https://doi.org/10.1016/j.taap.2010.05.008
  40. Jeong A, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H, Kim SH. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of P38 mitogen activated protein kinase and Akt in human umbilical vein endothelial cells. Biol Pharm Bull 2010;33:945-50. https://doi.org/10.1248/bpb.33.945
  41. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;53:557-73.
  42. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21. https://doi.org/10.1161/01.RES.65.1.1
  43. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
  44. Yu J, Eto M, Akishita M, Kaneko A, Ouchi Y, Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 2007;353:764-9. https://doi.org/10.1016/j.bbrc.2006.12.119
  45. Leung KW, Cheng YK, Mak NK, Chan KK, Fan TP, Wong RN. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006;580:3211-6. https://doi.org/10.1016/j.febslet.2006.04.080
  46. Kang YJ, Sohn JT, Chang KC. Relaxation of canine corporal smooth muscle relaxation by ginsenoside saponin Rg3 is independent from eNOS activation. Life Sci 2005;77:74-84. https://doi.org/10.1016/j.lfs.2004.12.016
  47. Jovanovski E, Jenkins A, Dias AG, Peeva V, Sievenpiper J, Arnason JT, Rahelic D, Josse RG, Vuksan V. Effects of Korean red ginseng (Panax Ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals. Am J Hypertens 2010;23:469-72. https://doi.org/10.1038/ajh.2010.5
  48. Lee JY, Lim KM, Kim SY, Bae ON, Noh JY, Chung SM, Kim K, Shin YS, Lee MY, Chung JH. Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng. Toxicol Sci 2010;117: 505-14. https://doi.org/10.1093/toxsci/kfq201
  49. Wang T, Yu XF, Qu SC, Xu HL, Sui DY. Ginsenoside Rb3 inhibits angiotensin IIinduced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol 2010;107:685-9. https://doi.org/10.1111/j.1742-7843.2010.00560.x
  50. Rhee MY, Kim YS, Bae JH, Nah DY, Kim YK, Lee MM, Kim HY. Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. J Altern Complement Med 2011;17:45-9. https://doi.org/10.1089/acm.2010.0065
  51. Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, Kim SH, Chang SJ, Nam KY. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol 2000;35:135-41. https://doi.org/10.1016/S0306-3623(01)00096-9
  52. Shin W, Yoon J, Oh GT, Ryoo S. Korean red ginseng inhibits arginase and contributes to endothelium-dependent vasorelaxation through endothelial nitric oxide synthase coupling. J Ginseng Res 2013;37:64-73. https://doi.org/10.5142/jgr.2013.37.64
  53. Vuksan V, Stavro M, Woo M, Leiter LA, Sung MK, Sievenpiper JL. Korean red ginseng (Panax ginseng) can lower blood pressure in individuals with hypertension: a randomized controlled trial. In: Proceedings of the 9th International Ginseng Symposium. Geumsan: Korean Society of Ginseng; 2006, p. 35-6.
  54. Baek EB, Yoo HY, Park SJ, Chung YS, Hong EK, Kim SJ. Inhibition of arterial myogenic responses by a mixed aqueous extract of Salvia miltiorrhiza and Panax notoginseng (PASEL) showing antihypertensive effects. Korean J Physiol Pharmacol 2009;13:287-93. https://doi.org/10.4196/kjpp.2009.13.4.287
  55. Wagner HN, Liu X. The international textbook of cardiology. New York: Pergamon Press; 1987.
  56. Liu L, Shi R, Shi Q, Cheng Y, Huo Y. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice. Planta Med 2008;74:203-9. https://doi.org/10.1055/s-2008-1034303
  57. Qin N, Gong QH, Wei LW, Wu Q, Huang XN. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol Pharm Bull 2008;31:1530-5. https://doi.org/10.1248/bpb.31.1530
  58. Deng J, Wang YW, Chen WM, Wu Q, Huang XN. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 2010;33:631-5. https://doi.org/10.1248/bpb.33.631
  59. Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H851-9. https://doi.org/10.1152/ajpheart.01242.2007
  60. Wang Z, Li M, Wu WK, Tan HM, Geng DF. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther 2008;22:443-52. https://doi.org/10.1007/s10557-008-6129-4
  61. Deng J, Lv XT, Wu Q, Huang XN. Ginsenoside Rg(1) inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin and mitogen-activated protein kinase signalings. Eur J Pharmacol 2009;608:42-7. https://doi.org/10.1016/j.ejphar.2009.01.048
  62. Wang YL, Wang CY, Zhang BJ, Zhang ZZ. Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro. Mol Biol Rep 2009;36:365-70. https://doi.org/10.1007/s11033-007-9188-x
  63. Zhu D, Wu L, Li CR, Wang XW, Ma YJ, Zhong ZY, Zhao HB, Cui J, Xun SF, Huang XL, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/ reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009;108:117-24. https://doi.org/10.1002/jcb.22233
  64. Kim TH, Lee SM. The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart. Food Chem Toxicol 2010;48:1516-20. https://doi.org/10.1016/j.fct.2010.03.018
  65. Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 2011;38:4327-35. https://doi.org/10.1007/s11033-010-0558-4
  66. Bodiga S, Wang W, Oudit GY. Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies. J Mol Med (Berl) 2011;89:317-20. https://doi.org/10.1007/s00109-011-0736-4
  67. Guo J, Gan XT, Haist JV, Rajapurohitam V, Zeidan A, Faruq NS, Karmazyn M. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ Heart Fail 2011;4: 79-88. https://doi.org/10.1161/CIRCHEARTFAILURE.110.957969
  68. Tsutsumi YM, Tsutsumi R, Mawatari K, Nakaya Y, Kinoshita M, Tanaka K, Oshita S, Compound K. a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/Pi3k pathway. Life Sci 2011;88:725-9. https://doi.org/10.1016/j.lfs.2011.02.011
  69. Zhou H, Hou SZ, Luo P, Zeng B, Wang JR, Wong YF, Jiang ZH, Liu L. Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated risk pathway in an endothelial NOS-dependent mechanism. J Ethnopharmacol 2011;135:287-98. https://doi.org/10.1016/j.jep.2011.03.015
  70. Tamura Y. Effects of Korean red ginseng on eicosanoid biosynthesis in platelets and vascular smooth muscle cells. In: Proceedings of the 6th International Ginseng Symposium. Seoul: Korean Society of Ginseng; 1993. p. 28-9.
  71. Dong-Ha Lee DH, Cho HJ, Kim HH, Rhee MH, Ryu JH, Park JH. Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser157 phosphorylation on thrombin-induced platelet aggregation. J Ginseng Res 2013;37:176-86. https://doi.org/10.5142/jgr.2013.37.176
  72. Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, Im JH, Han XH, Kim TJ, Shin KS, et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007;100:170-5. https://doi.org/10.1111/j.1742-7843.2006.00033.x
  73. Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol 2008;60:1531-6. https://doi.org/10.1211/jpp.60.11.0015
  74. Li GX, Liu ZQ. The protective effects of ginsenosides on human erythrocytes against hemin-induced hemolysis. Food Chem Toxicol 2008;46:886-92. https://doi.org/10.1016/j.fct.2007.10.020
  75. Yang JY, Sun K, Wang CS, Guo J, Xue X, Liu YY, Zheng J, Fan JY, Liao FL, Han JY. Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Clin Hemorheol Microcirc 2008;40:119-31.
  76. Lee JG, Lee YY, Wu B, Kim SY, Lee YJ, Yun-Choi HS, Park JH. Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation. Pharmazie 2010;65:520-2.
  77. Lee YH, Lee BK, Choi YJ, Yoon IK, Chang BC, Gwak HS. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int J Cardiol 2010;145:275-6. https://doi.org/10.1016/j.ijcard.2009.09.553
  78. Yi XQ, Li T, Wang JR, Wong VK, Luo P, Wong IY, Jiang ZH, Liu L, Zhou H. Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling. Phytomedicine 2010;17: 1006-15. https://doi.org/10.1016/j.phymed.2010.06.012
  79. Ahn CM, Hong SJ, Choi SC, Park JH, Kim JS, Lim DS. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res 2011;25:239-49.
  80. Trinh HT, Han SJ, Kim SW, Lee YC, Kim DH. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol 2007;17:1127-33.
  81. Hwang SY, Son DJ, Kim IW, Kim DM, Sohn SH, Lee JJ, Kim SK. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 2008;22:778-83. https://doi.org/10.1002/ptr.2363
  82. Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin Exp Pharmacol Physiol 2008;35:1238-44. https://doi.org/10.1111/j.1440-1681.2008.04997.x
  83. Liu G, Wang B, Zhang J, Jiang H, Liu F. Total Panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression. J Ethnopharmacol 2009;126:350-4. https://doi.org/10.1016/j.jep.2009.08.014
  84. Jia Y, Li ZY, Zhang HG, Li HB, Liu Y, Li XH. Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells. J Ethnopharmacol 2010;132:297-302. https://doi.org/10.1016/j.jep.2010.08.033
  85. Kwak YS, Kyung JS, Kim JS, Cho JY, Rhee MH. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol Pharm Bull 2010;33:468-72. https://doi.org/10.1248/bpb.33.468
  86. Li J, Xie ZZ, Tang YB, Zhou JG, Guan YY. Ginsenoside-Rd, a purified component from Panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. Eur J Pharmacol 2011;652:104-10. https://doi.org/10.1016/j.ejphar.2010.11.017
  87. Cai BX, Li XY, Chen JH, Tang YB, Wang GL, Zhou JG, Qui QY, Guan YY. Ginsenoside-Rd, a new voltage-independent $Ca^{2+}$ entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats. Eur J Pharmacol 2009;606:142-9. https://doi.org/10.1016/j.ejphar.2009.01.033
  88. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000;87:275-81. https://doi.org/10.1161/01.RES.87.4.275
  89. Chen RJ, Chung TY, Li FY, Lin NH, Tzen JT. Effect of sugar positions in ginsenosides and their inhibitory potency on $Na^+$/$K^+$-ATPase activity. Acta Pharmacol Sin 2009;30:61-9. https://doi.org/10.1038/aps.2008.6

Cited by

  1. Biotransformation of Ginsenosides Re and Rg1 by the Bacterium Microbacterium sp. GT35 vol.51, pp.1, 2014, https://doi.org/10.1007/s10600-015-1208-9
  2. Isolation and characterization of Panax ginseng geranylgeranyl-diphosphate synthase genes responding to drought stress vol.142, pp.4, 2014, https://doi.org/10.1007/s10658-015-0648-1
  3. Chemical diversity of ginseng saponins from Panax ginseng vol.39, pp.4, 2014, https://doi.org/10.1016/j.jgr.2014.12.005
  4. An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases vol.36, pp.11, 2014, https://doi.org/10.1038/aps.2015.70
  5. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models vol.5, pp.119, 2015, https://doi.org/10.1039/c5ra20559j
  6. Enzymatic transformation of vina-ginsenoside R7 to rare notoginsenoside ST-4 using a new recombinant glycoside hydrolase from Herpetosiphon aurantiacus vol.99, pp.8, 2014, https://doi.org/10.1007/s00253-015-6446-z
  7. 인체심장의 심부전모델에서의 獨蔘湯 투여에 따른 심장막전위 분석에 관한 연구 vol.23, pp.1, 2015, https://doi.org/10.14374/hfs.2015.23.1.121
  8. Highly efficient biotransformation of ginsenoside Rb1 and Rg3 using β-galactosidase from Aspergillus sp. vol.5, pp.96, 2014, https://doi.org/10.1039/c5ra11519a
  9. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways vol.73, pp.None, 2015, https://doi.org/10.1016/j.vph.2015.04.003
  10. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation vol.19, pp.6, 2014, https://doi.org/10.1089/rej.2015.1801
  11. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice vol.44, pp.6, 2014, https://doi.org/10.1142/s0192415x16500610
  12. Anti-Inflammatory and Antinociceptive Activities of Anthraquinone-2-Carboxylic Acid vol.2016, pp.None, 2014, https://doi.org/10.1155/2016/1903849
  13. Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future vol.2016, pp.None, 2014, https://doi.org/10.1155/2016/8958721
  14. Pretreatment with Ginseng Fruit Saponins Affects Serotonin Expression in an Experimental Comorbidity Model of Myocardial Infarction and Depression vol.7, pp.6, 2014, https://doi.org/10.14336/ad.2016.0729
  15. Nutrition Supplements to Stimulate Lipolysis: A Review in Relation to Endurance Exercise Capacity vol.62, pp.3, 2016, https://doi.org/10.3177/jnsv.62.141
  16. Isolation, Purification and Quantification of Ginsenoside F 5 and F 3 Isomeric Compounds from Crude Extracts of Flower Buds of Panax ginseng vol.21, pp.3, 2014, https://doi.org/10.3390/molecules21030315
  17. Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction vol.6, pp.None, 2016, https://doi.org/10.1038/srep22474
  18. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress‐induced apoptosis in a streptozotocin‐induced diabetes rat model vol.20, pp.4, 2016, https://doi.org/10.1111/jcmm.12739
  19. Comprehensive Evaluation of Deep Eutectic Solvents in Extraction of Bioactive Natural Products vol.4, pp.4, 2014, https://doi.org/10.1021/acssuschemeng.6b00091
  20. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model vol.13, pp.6, 2016, https://doi.org/10.3892/mmr.2016.5103
  21. Syk and IRAK1 Contribute to Immunopharmacological Activities of Anthraquinone-2-carboxlic Acid vol.21, pp.6, 2014, https://doi.org/10.3390/molecules21060809
  22. Fast quantitative analysis of ginsenosides in Asian ginseng (Panax ginseng C. A. Mayer) by using solid‐phase methylation coupled to direct analysis in real time vol.30, pp.suppl1, 2014, https://doi.org/10.1002/rcm.7627
  23. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway vol.48, pp.8, 2014, https://doi.org/10.1093/abbs/gmw049
  24. A Continuous Fractionation of Ginsenosides and Polysaccharides From Panax ginseng Using Supercritical Carbon Dioxide Technology vol.40, pp.4, 2014, https://doi.org/10.1111/jfpp.12655
  25. Dissipation and residues of the diamide insecticide chlorantraniliprole in ginseng ecosystems under different cultivation environments vol.189, pp.11, 2014, https://doi.org/10.1007/s10661-017-6241-7
  26. Engineering of mesoporous silica nanoparticles for release of ginsenoside CK and Rh2 to enhance their anticancer and anti-inflammatory efficacy: in vitro studies vol.19, pp.7, 2014, https://doi.org/10.1007/s11051-017-3949-9
  27. Vasodilatory Effects of Combined Traditional Chinese Medicinal Herbs in Optimized Ratio vol.20, pp.3, 2014, https://doi.org/10.1089/jmf.2016.3836
  28. Multiple Effects of Ginseng Berry Polysaccharides: Plasma Cholesterol Level Reduction and Enteric Neoplasm Prevention vol.45, pp.6, 2014, https://doi.org/10.1142/s0192415x17500719
  29. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure vol.66, pp.3, 2014, https://doi.org/10.1538/expanim.16-0121
  30. Anti-adipogenic Effects and Mechanisms of Ginsenoside Rg3 in Pre-adipocytes and Obese Mice vol.8, pp.None, 2014, https://doi.org/10.3389/fphar.2017.00113
  31. Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway vol.8, pp.None, 2014, https://doi.org/10.3389/fphar.2017.00783
  32. Enhanced anticancer effects of a mixture of low-dose mushrooms and Panax ginseng root extracts in human colorectal cancer cells vol.38, pp.3, 2014, https://doi.org/10.3892/or.2017.5796
  33. Preparation of Ginseng Extract with Enhanced Levels of Ginsenosides Rg1 and Rb1 Using High Hydrostatic Pressure and Polysaccharide Hydrolases vol.13, pp.49, 2017, https://doi.org/10.4103/0973-1296.203992
  34. Changbai Mountain Ginseng ( Panax ginseng C.A. Mey) Extract Supplementation Improves Exercise Performance and Energy Utilization and Decreases Fatigue-Associated Parameters in Mice vol.22, pp.2, 2017, https://doi.org/10.3390/molecules22020237
  35. Ginsenoside Rg5 increases cardiomyocyte resistance to ischemic injury through regulation of mitochondrial hexokinase-II and dynamin-related protein 1 vol.8, pp.2, 2014, https://doi.org/10.1038/cddis.2017.43
  36. Comparative analysis of the expression level of recombinant ginsenoside-transforming β -glucosidase in GRAS hosts and mass production of the ginsenoside Rh 2 -Mix vol.12, pp.4, 2014, https://doi.org/10.1371/journal.pone.0176098
  37. 금 나노입자를 처리한 홍삼의 산화스트레스 완화 및 PC-12 신경세포 보호 vol.49, pp.2, 2014, https://doi.org/10.9721/kjfst.2017.49.2.222
  38. Yeast Extract Stimulates Ginsenoside Production in Hairy Root Cultures of American Ginseng Cultivated in Shake Flasks and Nutrient Sprinkle Bioreactors vol.22, pp.6, 2014, https://doi.org/10.3390/molecules22060880
  39. Impairment of preimplantation and postimplantation embryonic development through intrinsic apoptotic processes by ginsenoside Rg1 in vitro and in vivo vol.32, pp.7, 2014, https://doi.org/10.1002/tox.22416
  40. Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats vol.18, pp.7, 2014, https://doi.org/10.3390/ijms18071364
  41. Ginsenoside Rg3 attenuates sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux vol.37, pp.4, 2014, https://doi.org/10.1042/bsr20170934
  42. The Effect of Fungicides on Mycelial Growth and Conidial Germination of the Ginseng Root Rot Fungus, Cylindrocarpon destructans vol.45, pp.3, 2014, https://doi.org/10.5941/myco.2017.45.3.220
  43. Gram-Scale Production of Ginsenoside F1 Using a Recombinant Bacterial β-Glucosidase vol.27, pp.9, 2014, https://doi.org/10.4014/jmb.1703.03006
  44. Herbal products containing Hibiscus sabdariffa L., Crataegus spp., and Panax spp.: Labeling and safety concerns vol.100, pp.1, 2014, https://doi.org/10.1016/j.foodres.2017.07.031
  45. Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activation vol.7, pp.None, 2014, https://doi.org/10.1038/s41598-017-13436-7
  46. Panax ginseng as an adjuvant treatment for Alzheimer's disease vol.42, pp.4, 2014, https://doi.org/10.1016/j.jgr.2017.12.008
  47. Metabolic profiling of flavonoids, saponins, alkaloids, and terpenoids in the extract from Vernonia cinerea leaf using LC-Q-TOF-MS vol.41, pp.11, 2014, https://doi.org/10.1080/10826076.2018.1511995
  48. Recent Advances in Drug Delivery System for Bioactive Glycosides from Traditional Chinese Medicine vol.46, pp.8, 2014, https://doi.org/10.1142/s0192415x18500908
  49. Effects of Panax ginseng on Obesity in Animal Models: A Systematic Review and Meta-Analysis vol.2018, pp.None, 2014, https://doi.org/10.1155/2018/2719794
  50. Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/6874692
  51. Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/9469670
  52. Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2 vol.12, pp.None, 2014, https://doi.org/10.3389/fncel.2018.00074
  53. Panax ginseng Polysaccharide Protected H9c2 Cardiomyocyte From Hypoxia/Reoxygenation Injury Through Regulating Mitochondrial Metabolism and RISK Pathway vol.9, pp.None, 2014, https://doi.org/10.3389/fphys.2018.00699
  54. High Levels of Ginsenosides Production Associated with rolC Gene Transcription and Expression in Ginseng Hairy Roots vol.14, pp.5, 2014, https://doi.org/10.3923/ijp.2018.615.623
  55. Eisenia bicyclis (brown alga) modulates platelet function and inhibits thrombus formation via impaired P2Y12 receptor signaling pathway vol.40, pp.None, 2014, https://doi.org/10.1016/j.phymed.2018.01.003
  56. Ginsenoside-Rg1 Protects against Renal Fibrosis by Regulating the Klotho/TGF-β1/Smad Signaling Pathway in Rats with Obstructive Nephropathy vol.41, pp.4, 2014, https://doi.org/10.1248/bpb.b17-00934
  57. Compound K Inhibits the Lipopolysaccharide-Induced Inflammatory Responses in Raw 264.7 Cell Line and Zebrafish vol.8, pp.6, 2014, https://doi.org/10.3390/app8060924
  58. Ginseng plantations threaten China’s forests vol.27, pp.8, 2014, https://doi.org/10.1007/s10531-018-1530-1
  59. Efficacy and safety of Shenfu injection for patients with return of spontaneous circulation after sudden cardiac arrest : Protocol for a systematic review and meta-analysis vol.97, pp.38, 2014, https://doi.org/10.1097/md.0000000000012500
  60. The Increase of Triterpene Saponin Production Induced by Trans -Anethole in Hairy Root Cultures of Panax quinquefolium vol.23, pp.10, 2014, https://doi.org/10.3390/molecules23102674
  61. Effects of Red Ginseng Extract on the Pharmacokinetics and Elimination of Methotrexate via Mrp2 Regulation vol.23, pp.11, 2014, https://doi.org/10.3390/molecules23112948
  62. Aqueous Extract of Taegeuk Ginseng Inhibits Platelet Aggregation and Thrombus Formation vol.21, pp.11, 2018, https://doi.org/10.1089/jmf.2017.4145
  63. Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca 2+ Levels via Cyclic Adenosine Monophosphate Dependent Manner vol.23, pp.4, 2018, https://doi.org/10.3746/pnf.2018.23.4.317
  64. 홍삼의 Dexamethasone 유도 근감소증 모델 백서에 대한 효과 연구 vol.39, pp.6, 2018, https://doi.org/10.22246/jikm.2018.39.6.1168
  65. Optimization of ginseng hairy roots culture and its ginsenoside analysis vol.35, pp.4, 2014, https://doi.org/10.12925/jkocs.2018.35.4.995
  66. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over vol.58, pp.3, 2014, https://doi.org/10.1007/s00394-018-1642-0
  67. Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer vol.21, pp.1, 2014, https://doi.org/10.1007/s10544-019-0374-0
  68. Electrodeposition of Ginseng/Polyaniline Encapsulated Poly(lactic-co-glycolic Acid) Microcapsule Coating on Stainless Steel 316L at Different Deposition Parameters vol.67, pp.5, 2014, https://doi.org/10.1248/cpb.c18-00847
  69. Bar-HRM: a reliable and fast method for species identification of ginseng (Panax ginseng, Panax notoginseng, Talinum paniculatum and Phytolacca Americana) vol.7, pp.None, 2019, https://doi.org/10.7717/peerj.7660
  70. A stereo-selective growth inhibition profile of ginsenoside Rh2 on human colon cancer cells vol.17, pp.1, 2019, https://doi.org/10.1080/19476337.2019.1607562
  71. Ginsenoside Rb1 Blocks Ritonavir-Induced Oxidative Stress and eNOS Downregulation through Activation of Estrogen Receptor-Beta and Upregulation of SOD in Human Endothelial Cells vol.20, pp.2, 2019, https://doi.org/10.3390/ijms20020294
  72. Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats vol.2019, pp.None, 2014, https://doi.org/10.1155/2019/3714508
  73. A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/7125162
  74. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review vol.29, pp.1, 2014, https://doi.org/10.1080/13543776.2019.1556258
  75. Mechanisms of action of Panax notoginseng ethanolic extract for its vasodilatory effects and partial characterization of vasoactive compounds vol.42, pp.2, 2019, https://doi.org/10.1038/s41440-018-0139-9
  76. The inhibitory effects of ginsenoside Rd on the human glioma U251 cells and its underlying mechanisms vol.120, pp.3, 2019, https://doi.org/10.1002/jcb.27732
  77. Analysis of major ginsenosides in various ginseng samples vol.62, pp.1, 2014, https://doi.org/10.3839/jabc.2019.013
  78. Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects vol.24, pp.10, 2014, https://doi.org/10.3390/molecules24101856
  79. Optimization of dynamic-microwave assisted enzymatic hydrolysis extraction of total ginsenosides from stems and leaves of panax ginseng by response surface methodology vol.49, pp.5, 2014, https://doi.org/10.1080/10826068.2018.1451883
  80. 피부각질세포 HaCaT에서 진세노사이드 Rb1에 의한 유전자 발현 양상 vol.29, pp.5, 2019, https://doi.org/10.5352/jls.2019.29.5.514
  81. Ginseng Berry Prevents Alcohol-Induced Liver Damage by Improving the Anti-Inflammatory System Damage in Mice and Quality Control of Active Compounds vol.20, pp.14, 2014, https://doi.org/10.3390/ijms20143522
  82. The content of triterpene saponins and phenolic compounds in American ginseng hairy root extracts and their antioxidant and cytotoxic properties vol.138, pp.2, 2019, https://doi.org/10.1007/s11240-019-01633-3
  83. Panax notoginsenoside Rb1 Restores the Neurotrophic Imbalance Following Photothrombotic Stroke in Rats vol.36, pp.3, 2014, https://doi.org/10.1007/s12640-019-00058-2
  84. Ginsenoside Rb1 ameliorates CKD‐associated vascular calcification by inhibiting the Wnt/β‐catenin pathway vol.23, pp.10, 2014, https://doi.org/10.1111/jcmm.14611
  85. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products vol.71, pp.4, 2019, https://doi.org/10.1124/pr.118.017178
  86. Improvement of phytochemical production by plant cells and organ culture and by genetic engineering vol.38, pp.10, 2014, https://doi.org/10.1007/s00299-019-02415-z
  87. Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer vol.19, pp.25, 2014, https://doi.org/10.2174/1568026619666191018100848
  88. Interactions of ginseng with therapeutic drugs vol.42, pp.10, 2014, https://doi.org/10.1007/s12272-019-01184-3
  89. Effects of different substrates on low‐temperature storage of fresh ginseng vol.99, pp.14, 2014, https://doi.org/10.1002/jsfa.9899
  90. Development of a Validated UPLC-MS/MS Method for Analyzing Major Ginseng Saponins from Various Ginseng Species vol.24, pp.22, 2019, https://doi.org/10.3390/molecules24224065
  91. In vitro and in silico evaluation of stereoselective effect of ginsenoside isomers on platelet P2Y12 receptor vol.64, pp.None, 2014, https://doi.org/10.1016/j.phymed.2019.152899
  92. Energy drinks: health effects and consumer safety vol.49, pp.6, 2014, https://doi.org/10.1108/nfs-11-2018-0331
  93. Ginsenoside Rb1 exerts antiarrhythmic effects by inhibiting I Na and I CaL in rabbit ventricular myocytes vol.9, pp.1, 2014, https://doi.org/10.1038/s41598-019-57010-9
  94. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms vol.47, pp.12, 2014, https://doi.org/10.1124/dmd.119.087965
  95. Ginsenosides Rb1 and Rg1 Protect Primary Cultured Astrocytes against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury via Improving Mitochondrial Function vol.20, pp.23, 2014, https://doi.org/10.3390/ijms20236086
  96. Ginsenoside Rh2 Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing NF-kappaB-Mediated Thymic Stromal Lymphopoietin Expression and T Helper Type 2 Differentiation vol.20, pp.24, 2014, https://doi.org/10.3390/ijms20246111
  97. A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks vol.48, pp.2, 2014, https://doi.org/10.1142/s0192415x20500147
  98. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems vol.27, pp.4, 2020, https://doi.org/10.2174/0929867326666190809221332
  99. Ginsenoside Rb1 pretreatment attenuates myocardial ischemia by reducing calcium/calmodulin-dependent protein kinase II-medicated calcium release vol.6, pp.3, 2014, https://doi.org/10.4103/wjtcm.wjtcm_24_20
  100. Antihypertensive Effects of Rg3-Enriched Korean Vitamin Ginseng in Spontaneously Hypertensive Rats vol.15, pp.1, 2014, https://doi.org/10.1177/1934578x19900712
  101. Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition vol.58, pp.1, 2014, https://doi.org/10.1080/13880209.2020.1831026
  102. Strontium Modified Calcium Sulfate Hemihydrate Scaffold Incorporating Ginsenoside Rg1/Gelatin Microspheres for Bone Regeneration vol.8, pp.None, 2014, https://doi.org/10.3389/fbioe.2020.00888
  103. Energy Metabolism Mechanism of Anticardiogenic Shock Effect Component Ginsenoside Rc of Shenfu Injection on H9c2 Myocardial Injury Cells Induced by Hypoxia/Reoxygenation vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/1828629
  104. Qidong Yixin Oral Liquid for Viral Myocarditis: A Systematic Review and Meta-Analysis vol.2020, pp.None, 2014, https://doi.org/10.1155/2020/4704535
  105. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/6565396
  106. Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells vol.10, pp.None, 2020, https://doi.org/10.3389/fphar.2019.01565
  107. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety vol.11, pp.None, 2014, https://doi.org/10.3389/fphar.2020.00422
  108. Herb–Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats vol.25, pp.3, 2020, https://doi.org/10.3390/molecules25030622
  109. Characterization and Antioxidant Activity Determination of Neutral and Acidic Polysaccharides from Panax Ginseng C. A. Meyer vol.25, pp.4, 2014, https://doi.org/10.3390/molecules25040791
  110. Biotechnological Interventions for Ginsenosides Production vol.10, pp.4, 2020, https://doi.org/10.3390/biom10040538
  111. Korean Red Ginseng Suppresses the Expression of Oxidative Stress Response and NLRP3 Inflammasome Genes in Aged C57BL/6 Mouse Ovaries vol.9, pp.4, 2014, https://doi.org/10.3390/foods9040526
  112. Nutraceutical Potential of Diet Drinks: A Critical Review on Components, Health Effects, and Consumer Safety vol.39, pp.3, 2020, https://doi.org/10.1080/07315724.2019.1642811
  113. Oleanane-Type Saponins From the Aerial Parts of Panax bipinnatifidus vol.15, pp.5, 2014, https://doi.org/10.1177/1934578x20926278
  114. Anti-Inflammatory Potential of Cultured Ginseng Roots Extract in Lipopolysaccharide-Stimulated Mouse Macrophages and Adipocytes vol.17, pp.13, 2014, https://doi.org/10.3390/ijerph17134716
  115. Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of Panax ginseng vol.34, pp.13, 2020, https://doi.org/10.1002/rcm.8788
  116. Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions vol.44, pp.4, 2014, https://doi.org/10.1016/j.jgr.2020.03.001
  117. Advances in Saponin Diversity of Panax ginseng vol.25, pp.15, 2014, https://doi.org/10.3390/molecules25153452
  118. Ginseng-Induced Changes to Blood Vessel Dilation and the Metabolome of Rats vol.12, pp.8, 2020, https://doi.org/10.3390/nu12082238
  119. Enhancement of an In Vivo Anti-Inflammatory Activity of Oleanolic Acid through Glycosylation Occurring Naturally in Stauntonia hexaphylla vol.25, pp.16, 2020, https://doi.org/10.3390/molecules25163699
  120. The Effects of Wild Ginseng Extract on Psychomotor and Neuromuscular Performance Recovery Following Acute Eccentric Exercise: A Preliminary Study vol.10, pp.17, 2020, https://doi.org/10.3390/app10175839
  121. The Development and Validation of a Novel “Dual Cocktail” Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions vol.12, pp.10, 2014, https://doi.org/10.3390/pharmaceutics12100938
  122. The Advances on the Protective Effects of Ginsenosides on Myocardial Ischemia and Ischemia-Reperfusion Injury vol.20, pp.16, 2020, https://doi.org/10.2174/1389557520666200619115444
  123. Effect of Korean Red Ginseng on Cholesterol Metabolites in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial vol.12, pp.11, 2014, https://doi.org/10.3390/nu12113423
  124. MicroRNAs mediate the anti-tumor and protective effects of ginsenosides vol.72, pp.8, 2014, https://doi.org/10.1080/01635581.2019.1675722
  125. Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria vol.25, pp.22, 2014, https://doi.org/10.3390/molecules25225230
  126. Ginseng attenuates fipronil-induced hepatorenal toxicity via its antioxidant, anti-apoptotic, and anti-inflammatory activities in rats vol.27, pp.36, 2014, https://doi.org/10.1007/s11356-020-10306-0
  127. 상업용 β-glucanase를 이용한 홍삼유래 사포닌으로부터 Ginsnoside Rd 의 생물 전환 vol.46, pp.4, 2014, https://doi.org/10.15230/scsk.2020.46.4.349
  128. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases vol.41, pp.1, 2014, https://doi.org/10.1002/med.21743
  129. Simultaneous Quantification of Four Ginsenosides in Rat Plasma and Its Application to a Comparative Pharmacokinetic Study in Normal and Depression Rats Using UHPLC-MS/MS vol.2021, pp.None, 2014, https://doi.org/10.1155/2021/4488822
  130. Ginsenoside Rb1 Alleviates Lipopolysaccharide-Induced Inflammatory Injury by Downregulating miR-222 in WI-38 Cells vol.30, pp.None, 2014, https://doi.org/10.1177/09636897211002787
  131. Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial vol.134, pp.2, 2014, https://doi.org/10.1097/cm9.0000000000001257
  132. Correlation between the Content and Pharmacokinetics of Ginsenosides from Four Different Preparation of Panax Ginseng C.A. Meyer in Rats vol.12, pp.1, 2021, https://doi.org/10.5478/msl.2021.12.1.16
  133. Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action vol.166, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105481
  134. Protocol Optimization of Proteomic Analysis of Korean Ginseng (Panax ginseng Meyer) vol.8, pp.4, 2014, https://doi.org/10.3390/separations8040053
  135. Effect of Korean Red Ginseng on metabolic syndrome vol.45, pp.3, 2014, https://doi.org/10.1016/j.jgr.2020.11.002
  136. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action vol.169, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105647
  137. Effect of Korean Red Ginseng on Plasma Ceramide Levels in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial vol.11, pp.7, 2014, https://doi.org/10.3390/metabo11070417
  138. Pharmacological Efficacy of Ginseng against Respiratory Tract Infections vol.26, pp.13, 2014, https://doi.org/10.3390/molecules26134095
  139. A Novel Biocontrol Strain Bacillus amyloliquefaciens FS6 for Excellent Control of Gray Mold and Seedling Diseases of Ginseng vol.105, pp.7, 2014, https://doi.org/10.1094/pdis-07-20-1593-re
  140. Phytochemicals and Amino Acids Profiles of Selected sub-Saharan African Medicinal Plants’ Parts Used for Cardiovascular Diseases’ Treatment vol.13, pp.9, 2014, https://doi.org/10.3390/pharmaceutics13091367
  141. Hair Growth-Promoting Mechanisms of Red Ginseng Extract through Stimulating Dermal Papilla Cell Proliferation and Enhancing Skin Health vol.26, pp.3, 2014, https://doi.org/10.3746/pnf.2021.26.3.275
  142. Gibberellins enhance plant growth and ginsenoside content in Panax ginseng vol.48, pp.3, 2021, https://doi.org/10.5010/jpb.2021.48.3.186
  143. Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics vol.26, pp.19, 2014, https://doi.org/10.3390/molecules26195969
  144. Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt/β‑catenin signaling vol.25, pp.24, 2014, https://doi.org/10.1111/jcmm.17028
  145. Ginsenoside Rg3 Attenuates TNF-α-Induced Damage in Chondrocytes through Regulating SIRT1-Mediated Anti-Apoptotic and Anti-Inflammatory Mechanisms vol.10, pp.12, 2014, https://doi.org/10.3390/antiox10121972
  146. Hollongdione arylidene derivatives induce antiproliferative activity against melanoma and breast cancer through pro-apoptotic and antiangiogenic mechanisms vol.119, pp.None, 2022, https://doi.org/10.1016/j.bioorg.2021.105535